Oncofactor's Series A - II Round

Oncofactor raised a round of funding on September 03, 2013.

Oncofactor is developing an oncology platform to identify and target immune modulating proteins differentially expressed by cancer cells. Conventional cancer therapies are either toxic to rapidly divi…

Articles about Oncofactor's Series A - II Round: